Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | MAT2A |
| Upstream (Parents) |
|---|
| (<<) ACTB → MAT2A |
| (<<) B3GNT2 → MAT2A |
| (<<) DAZAP2 → MAT2A |
| (<<) ENO1 → MAT2A |
| (<<) GAPDH → MAT2A |
| (<<) HSP90AB1 → MAT2A |
| (<<) HSPA8 → MAT2A |
| (<<) PGK1 → MAT2A |
| (<<) RHOA → MAT2A |
| (<<) TAGLN2 → MAT2A |
| (<<) UBE2N → MAT2A |
| Downstream (Children) |
|---|
| MAT2A → ADAM17 (>>) |
| MAT2A → BCL3 (>>) |
| MAT2A → BZW1 (>>) |
| MAT2A → BZW2 (>>) |
| MAT2A → CASP8 (>>) |
| MAT2A → CPD (>>) |
| MAT2A → CSNK1A1 (>>) |
| MAT2A → DHCR7 (>>) |
| MAT2A → DVL1 (>>) |
| MAT2A → EIF4E (>>) |
| MAT2A → EML4 (>>) |
| MAT2A → ERBB2 (>>) |
| MAT2A → FOXO3 (>>) |
| MAT2A → GLTPD1 (>>) |
| MAT2A → GNA13 (>>) |
| MAT2A → HSPA4 (>>) |
| MAT2A → MAP3K2 (>>) |
| MAT2A → MAP3K4 (>>) |
| MAT2A → MCL1 (>>) |
| MAT2A → MEGF6 (>>) |
| MAT2A → MTAP (>>) |
| MAT2A → NAB2 (>>) |
| MAT2A → NOTCH2 (>>) |
| MAT2A → PLAU (>>) |
| MAT2A → PPIF (>>) |
| MAT2A → PRKCI (>>) |
| MAT2A → PRKCZ (>>) |
| MAT2A → PRPF4B (>>) |
| MAT2A → PTK2 (>>) |
| MAT2A → RYK (>>) |
| MAT2A → SF3A2 (>>) |
| MAT2A → SLC29A1 (>>) |
| MAT2A → SPATA2L (>>) |
| MAT2A → TP53 (>>) |
| MAT2A → UBE2J1 (>>) |
| MAT2A → VEGFA (>>) |
| MAT2A → YWHAE (>>) |
| MAT2A → YWHAZ (>>) |
| MAT2A → ZNF205 (>>) |
